One US IPO planned for the week of Dec 17

By
A A A

The following IPOs are expected to price this week :

Audeo Oncology ( AURX ), which is developing a combination therapy in Phase 3 trial for metastatic colorectal cancer, plans to raise $49 million by offering 3.3 million shares at a price range of $14.00 to $16.00. At the midpoint of the proposed range, Audeo Oncology would command a market value of $163 million. Audeo Oncology, which was founded in 2006, booked $0 million in sales over the last 12 months. The San Francisco, CA-based company plans to list on the NASDAQ under the symbol AURX. Leerink Swann and Oppenheimer & Co. are the joint bookrunners on the deal.

Renaissance Capital will have Pre-IPO Research available on each of these upcoming IPOs prior to its pricing.

Last week, there were 3 IPO pricings . SolarCity ( SCTY ), which leases and installs solar energy systems for homes and businesses, was the week's winner, ending up 47% from its IPO price.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: News Headlines , IPOs

Referenced Stocks: AURX , SCTY

Renaissance Capital

Renaissance Capital

More from Renaissance Capital:

Related Videos

The Pumpkin Carvers
The Pumpkin Carvers                 

Stocks

Referenced

Most Active by Volume

88,066,694
  • $97.19 ▲ 2.61%
58,241,731
  • $71.29 ▲ 2.92%
51,058,864
  • $44.87 ▲ 0.09%
48,927,829
  • $28.75 ▲ 0.81%
46,551,917
    $15.52 unch
40,249,498
  • $3.46 ▼ 0.57%
38,633,031
  • $22.43 ▼ 9.63%
38,240,825
  • $34.71 ▲ 3.30%
As of 7/23/2014, 04:04 PM